Martin Bechem

This inventor holds 54 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Biomedical Assays (CPC class 5461). Top assignees: Bayer Aktiengesellschaft, Bayer Healthcare Aktiengesellschaft, Bayer Schering Pharma Ag. Active years: 1987-2013.

USPTO Granted Patents = 54 (Patent Applications = 1)

% Patents Active = 88.9

EPO Patents = 1

Average Co-Inventor Count = 6.1

ph-index = 10

Forward Citations = 445(Granted Patents)

Forward Citations (Not Self Cited) = 401(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

46 out of 12,266

Bayer Aktiengesellschaft

patents

4 out of 77

Bayer Healthcare Aktiengesellschaft

patents

1 out of 192

Bayer Schering Pharma Ag

patents

4. 1 out of 5

Cybio Instruments Gmbh

6. 1 out of 834,350

Other

patents

Years Active: 1987-2013

Loading Chart...

Areas of Expertise:

Fluorescence Measurement

Biomedical Assays

Microplate Technology

Dihydropyridines

Optical Analysis

Luminescence Detection

Pharmaceutical Compounds

Automatic Handling

Caged Compounds

Measurement Systems

Quinolines

Transport Systems

54 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8512652 - Multiwell microplate with transparent bottom having a thickness less than 200 micrometers (2013-08-20),

2. 8178359 - Masking of the background fluorescence and luminescence in the optical analysis of biomedical assays (2012-05-15),

3. 7615376 - Masking background fluorescence and luminescence in the optical analysis of biomedical assays (2009-11-10),

4. 7138280 - Masking of the background fluorescence and luminescence in the optical analysis of biomedical assays (2006-11-21),

5. 7063952 - Masking background flourescence and luminescence in optical analysis of biomedical assays (2006-06-20),

6. 6985225 - Fluorescence-measuring system (2006-01-10),

7. 6867206 - 6-carboxyphenyldihydropyridazinone derivatives and use thereof (2005-03-15),

8. 6699857 - Tetrahydroquinolinyl 6-methyldihydrothiadiazinone derivatives and use thereof (2004-03-02),

9. 6420183 - Masking background fluorescence and luminescence in optical analysis of biomedical assays (2002-07-16),

10. 6343906 - Arrangement for transporting microtitration plates in an automatic handling machine (2002-02-05),

11. 6191852 - Optical measurement system for detecting luminescence or fluorescence signals (2001-02-20),

12. 5721248 - 4-bicyclically substituted dihydropyridines, and their use in medicaments (1998-02-24),

13. 5629320 - 3-quinolyl-substituted dihydropyridines, and their use in medicaments (1997-05-13),

14. 5606066 - Light activable 'caged' 1-(2-nitrobenzyl)-substituted (1997-02-25),

15. 5550245 - 3-quinolyl-substituted dihydropyridines, processes for their preparation (1996-08-27),

Title: Martin Bechem: Innovator in Biomedical Assays

Introduction

Martin Bechem, based in Wuppertal, Germany, is a prolific inventor known for his contributions in the field of biomedical assays. With an impressive portfolio of 54 patents, Bechem has made significant strides in enhancing the sensitivity and accuracy of optical analyses.

Latest Patents

Among his latest innovations is a multiwell microplate with a transparent bottom, constructed with a maximum thickness of 500 micrometers. This design aims to improve the functionality of microplates used in various biomedical applications. Another notable invention addresses the masking of background fluorescence and luminescence during optical analysis. This process enhances the quantitative optical analysis of fluorescently labeled biological cells and contributes to the sensitivity of luminescent biological assays. Such processes also play crucial roles in receptor studies by minimizing interfering background radiation.

Career Highlights

Martin Bechem's career is marked by a tenure at Bayer Aktiengesellschaft and Bayer Healthcare Aktiengesellschaft. His work at these leading companies has allowed him to apply his innovative ideas in product development and research, further enhancing the company's standing in the biomedical field.

Collaborations

Throughout his career, Bechem has collaborated with esteemed colleagues such as Rainer Gross and Siegbert Hebisch. These partnerships have facilitated the exchange of ideas and expertise, contributing to the successful realization of various innovative projects.

Conclusion

Martin Bechem stands out as a key innovator in the realm of biomedical assays, pushing the boundaries of optical analysis through his remarkable inventions. His ongoing dedication to research and development continues to influence the medical and scientific communities, ensuring that his contributions will have a lasting impact in the field.